| Literature DB >> 28802875 |
Tom H Karlsen1, Trine Folseraas2, Douglas Thorburn3, Mette Vesterhus4.
Abstract
Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressive liver disease. Inflammatory bowel disease is usually present and there is a high risk of cholangiocarcinoma and colorectal cancer. Most patients ultimately require liver transplantation, after which disease recurrence may occur. With limited therapeutic options and a lack of proven surveillance strategies, patients currently have significant unmet needs. In the present seminar, we provide a comprehensive review of the status of the field. We emphasise developments related to patient stratification and disease behaviour, and provide an overview of management options from a practical, patient-centered perspective. We survey advances made in the understanding of PSC pathogenesis and summarise the ongoing efforts to develop an effective therapy based on these insights.Entities:
Keywords: Cholangiocarcinoma; IgG4-associated cholangitis; Primary sclerosing cholangitis
Mesh:
Year: 2017 PMID: 28802875 DOI: 10.1016/j.jhep.2017.07.022
Source DB: PubMed Journal: J Hepatol ISSN: 0168-8278 Impact factor: 25.083